Rosiglitazone (Avandia) and pioglitazone (Actos) and heart failure
- PMID: 11826947
- PMCID: PMC99278
Rosiglitazone (Avandia) and pioglitazone (Actos) and heart failure
References
-
- Important safety reminder for patients taking oral diabetes drugs of the glitazone class, Avandia® and Actos®. Ottawa: Health Canada; 2001 Nov 30. Available: www.hc-sc.gc.ca/english/protection/warnings/2001/2001_132e.htm (accessed 2001 Dec 17).
-
- Important safety information regarding Avandia® (rosiglitazone maleate). Mississauga (ON): GlaxoSmithKline; 2001 Nov 13. Available: www.hc-sc.gc.ca/hpb-dgps/therapeut/zfiles/english/advisory/industry/avan... (accessed 2001 Dec 17).
-
- Important safety information regarding Actos®. Toronto: Eli Lilly Canada Inc.; 2001 Nov 6. Available: www.hc-sc.gc.ca/hpb-dgps/therapeut/zfiles/english/advisory/industry/acto... (accessed 2001 Dec 17).
-
- McMorran M, Vu D. Rosiglitazone (Avandia): hepatic, cardiac and hematological reactions. Can ADR Newsl 2001;11(3):2-3. Also in CMAJ 2001; 165(1):82-3. Available: www.hc-sc.gc.ca/hpb-dgps/therapeut/zfiles/english/publicat/adrv11n3_e.html (accessed 2001 Dec 17). - PubMed
-
- Avandia®, rosiglitazone maleate tablets [product monograph]. Mississauga (ON): GlaxoSmithKline; 2001 Oct 19.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical